603811.SH
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 7.24
−2.16%Year over year
Reported trailing growth
- Revenue
- +10.8%
- EBITDA
- —
- EBIT
- -6.9%
- EPS
- -6.8%
- Free cash flow
- +1.5%
- Operating cash flow
- +10.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +7.4%
- EBITDA
- +12.1%
- EBIT
- +11.0%
- Net income
- +6.5%
- EPS
- +7.6%
- Free cash flow
- +37.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026